Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours

Abstract NTRK gene fusions are rare somatic mutations found across cancer types with promising targeted therapies emerging. Healthcare systems face significant challenges in integrating these treatments, with uncertainty in prevalence and optimal testing methods to identify eligible patients. We per...

Detaylı Bibliyografya
Asıl Yazarlar:	Sophie O’Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell, Jayesh Desai, Stephen Fox, Maarten IJzerman
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Nature Portfolio 2023-03-01
Seri Bilgileri:	Scientific Reports
Online Erişim:	https://doi.org/10.1038/s41598-023-31055-3

Benzer Materyaller

A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
Yazar:: Yoon-Jung Kang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
Yazar:: Simon Strohmeier, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

NTRK fusion in Japanese colorectal adenocarcinomas
Yazar:: Yuya Yamashiro, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

NTRK1 fusion in glioblastoma multiforme.
Yazar:: Jinkuk Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

<i>NTRK</i> Fusions in 1113 Solid Tumors in a Single Institution
Yazar:: Heejin Bang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors
Yazar:: Jeongwan Kang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors
Yazar:: Mariana Petaccia de Macedo, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Correction: NTRK1 Fusion in Glioblastoma Multiforme
Baskı/Yayın Bilgisi: (2014-01-01)

NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas
Yazar:: Zoltán Lippai, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinib
Yazar:: Rafal Dziadziuszko, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in China
Yazar:: Chunwei Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Case report: Adult NTRK-rearranged spindle cell neoplasms with TPM3-NTRK1 fusion in the pelvic
Yazar:: Qiurui Cao, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach
Yazar:: Fanny Franchini, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

NTRK fusions in osteosarcoma are rare and non‐functional events
Yazar:: Baptiste Ameline, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Molecular and clinicopathologic features of gliomas harboring NTRK fusions
Yazar:: Matthew Torre, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
Yazar:: C. B. Westphalen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
Yazar:: Qing-Xiang Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

NTRK-rearranged spindle cell tumor with SPECC1L-NTRK3 fusion in the thoracic spine: a case report
Yazar:: Mi Zhou, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

NTRK Somatic Fusions and Tumor Agnostic Treatment in Pediatric Cancers
Yazar:: Emel Ünal, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
Yazar:: Ben J. Friedman, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population
Yazar:: Ruiying Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

NTRK-fused central nervous system tumours: clinicopathological and genetic insights and response to TRK inhibitors
Yazar:: Eric Eunshik Kim, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Author Correction: Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world population
Yazar:: C. B. Westphalen, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions
Yazar:: Yinghuan Dai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Critical domains for NACC2-NTRK2 fusion protein activation.
Yazar:: Wei Yang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

NTRK Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects
Yazar:: Vasiliki Siozopoulou, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

<i>NTRK</i> Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects
Yazar:: Vasiliki Siozopoulou, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
Yazar:: Yuekun Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

Case report: STRN3-NTRK3 fusion in uterine sarcoma with spleen metastasis: a new variant in the spectrum of NTRK-rearranged tumors
Yazar:: Piergiuseppe Colombo, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan
Yazar:: Eiji Nakata, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Tumor Mutation Burden Survey of AACR GENIE Database Revealed NTRK (NTRK+) and RET (RET+) Fusions Positive Colorectal Carcinoma (CRC) as Distinct Subsets
Yazar:: Zhaohui Liao Arter, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

A case of thyroid carcinoma with mucinous features harboring ETV6-NTRK3 fusion: Expanding the morphologic spectrum of NTRK-rearranged thyroid carcinoma
Yazar:: Khaled A. Murshed, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Detection of <i>NTRK</i> Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
Yazar:: Bart Koopman, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Use of Diagnostic Algorithms for *NTRK* Fusion-Positive Tumors in Pathology Institutes in Switzerland
Yazar:: Holger Moch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors
Yazar:: Jin Sheng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Systematic population-based identification of NTRK and RET fusion-positive thyroid cancers
Yazar:: Markus Eszlinger, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma
Yazar:: Li Lei, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Use of Diagnostic Algorithms for NTRK Fusion-Positive Tumors in Pathology Institutes in Switzerland
Yazar:: Holger Moch, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies
Yazar:: Salvatore Siena, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Secretory carcinoma of major and minor salivary glands with ETV6-NTRK3 gene fusion: overcoming misdiagnosis in the era of tumour-agnostic therapy with TRK inhibitors
Yazar:: Monika Durzyńska, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)